T63536 |
Dual FAAH/sEH-IN-1
|
2756099-59-7
|
98%
|
|
Dual FAAH/sEH-IN-1 is a dual inhibitor of sEH (soluble epoxide hydrolase) (IC50: 9.6 nM) and FAAH (fatty acid amide hydrolase) (IC50: 7 nM) with high affinity an...
|
TN1438 |
Beta-Amyrin acetate
|
1616-93-9
|
98%
|
|
beta-Amyrin acetate inhibits HMG-CoA Reductase (HMGCR) and sEH activity with IC50 of 3.4 μM. beta-Amyrin acetate has anti-inflammatory, antifungal, antioxidant, ...
|
T9832 |
(Rac)-EC5026
|
1809885-55-9
|
98%
|
|
(Rac)-EC5026 ((Rac)-BPN-19186) is a potent piperidine inhibitor of soluble epoxide hydrolase (sEH) with Ki of 0.06 nM. (Rac)-EC5026 can be used for the research ...
|
T21859 |
ARM1
|
68729-05-5
|
98%
|
|
ARM1 is a potent inhibitor of aminopeptidase and epoxide hydrolase. The IC50 values are 7.61 µM for aminopeptidase and 12.4 µM for epoxide hydrolase.
|
T10900 |
CUDA
|
479413-68-8
|
98%
|
|
CUDA is an effective soluble cyclohydrolase inhibitor with IC50 of 11.1 nM and 112 nM for mouse sEH and human sEH, respectively. CUDA selectively increases the a...
|
T14315 |
AR-9281
|
913548-29-5
|
|
|
AR9281 is a potent and selective inhibitor of soluble epoxide hydrolase (s-EH) potentially for the treatment of hypertension and type 2 diabetes
|
T11147 |
EC5026
|
1809885-32-2
|
96.6%
|
|
EC5026 has the potential to relieve pain by stabilizing natural analgesic and anti-inflammatory mediators.
|
T14557 |
BI-1935
|
940954-41-6
|
97.55%
|
|
BI-1935 is an inhibitor of soluble epoxide hydrolase (sEH). For diseases related to cardiovascular disease.
|
T8315 |
1-Cyclohexyl-3-dodecyl urea
|
402939-18-8
|
98%
|
|
1-Cyclohexyl-3-dodecyl urea is a highly selective soluble epoxide hydrolase (sEH) inhibitor.
|
T7199 |
TPPU
|
1222780-33-7
|
98%
|
|
TPPU is a potent inhibitor of both human and mouse sEH (IC50 of 3.7 and 2.8 nM, respectively)
|
T7898 |
AUDA
|
479413-70-2
|
98%
|
|
AUDA is an inhibitor of sEH(IC50 values of 18 and 69 nM for the mouse and human enzymes, respectively)
|
T12580 |
PTUPB
|
1287761-01-6
|
99.15%
|
|
PTUPB is a potent and dual inhibitor of sEH and COX-2 enzymes(IC50 of 0.9 nM and 1.26 μM, respectively).
|
T8844 |
Diflapolin
|
724453-98-9
|
99.23%
|
|
Diflapolin is a highly active dual 5-lipoxygenase-activating protein (FLAP)/soluble epoxide hydrolase (sEH) inhibitor with marked anti-inflammatory efficacy and ...
|
T15430 |
GSK2256294A
|
1142090-23-0
|
99.27%
|
|
GSK2256294A is potent, selective inhibitor of recombinant human, rat and mouse sEH with IC50 of 27 pM, 61 pM and 189 pM, respectively.
|
T17158 |
Trans-AUCB
|
885012-33-9
|
99.27%
|
|
trans-AUCB is an effective and selective soluble epoxide hydrolase inhibitor (IC50s: 1.3 nM, 8 nM, 8 nM for hsEH, mouse sEH and rat sEH, respectively).
|
T17196 |
UC-1728
|
948304-40-3
|
99.88%
|
|
UC-1728 is an effective rabbit soluble epoxide hydrolase inhibitor (IC50: 2 nM on rabbit liver).
|
T2716 |
1,3-Diphenylurea
|
102-07-8
|
99.93%
|
|
1, 3-Diphenylurea is involved with Epoxide hydrolase activity.
|
T23044 |
N,N'-Dicyclohexylurea
|
2387-23-7
|
98%
|
|
soluble epoxide hydrolase (sEH) inhibitor
|
T0355 |
Valpromide
|
2430-27-5
|
98%
|
|
Valpromide is a carboxamide derivative of valproic acid, used in the treatment of epilepsy and some affective disorders.
|